Monographie - Omeprazole sodium

Son güncelleme :
29/10/2024

Omeprazole sodium

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Antra	Almanya, İsviçre, İtalya
Biomezol	Ekvador
Cezole	Peru
Ciplaprazole	Kolombiya
Dinsadrix	Meksika
Fendiprazole	Arjantin
Finulcer	Meksika
Fordex	Venezuela
Gaspiren	Brezilya
Gastromax	Venezuela
Gerdex	Meksika
Haitrax	Meksika
Helicid	Polonya
Imaroz	Şili
Inhibitron	Meksika
Ipproton	Suudi Arabistan, Tunus
Klomeprax	Arjantin, Ekvador
Lordin	Yunanistan
Losec	Avusturya, Belçika, Büyük Britanya, Hollanda, İtalya, Polonya, Suudi Arabistan, Türkiye
Mepral	İtalya
Omeprazen	İtalya
Omeprazol	Almanya
Omeprazole	Fransa
Oprazole	Suudi Arabistan
Penrazol	Yunanistan
Rizek	Suudi Arabistan
Timezol	Arjantin
Ulcozol	Arjantin
Ultop	Hırvatistan

Kaynaklar : Omeprazole sodium

	tip	yayın
186	Dergi	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264	Dergi	Leboucher G, Charpiat B. Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Pharm Hosp Fr 1997 ; 121: 124.
1703	Dergi	Schuster F, Bernard R. Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Krankenhauspharmazie 1995 ; 16: 101-103.
2231	Dergi	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311	Dergi	Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. J Clin Pharm Ther 2009 ; 34: 25-31.
3332	Laboratuar	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3658	Laboratuar	Omeprazole - Summary of Product Characteristics. Sandoz 2014
3823	Dergi	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3871	afiş	Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 2016
3976	Dergi	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	afiş	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4316	Dergi	Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion. J Pharm Technol 2006 ;22:95-98.
4642	afiş	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021

Mentions Légales